OBJECTIVE: San Francisco, California, has experienced a 44% reduction in new HIV diagnoses since 2013 supported by its 'Getting to Zero' initiative; however, the age-adjusted mortality rate in people with HIV (PWH) has not decreased. We sought to identify factors associated with death among PWH in San Francisco. DESIGN: Population-based incidence-density case-control study. METHODS: Among PWH in the San Francisco HIV surveillance registry, a random sample of 48 decedents from 1 July 2016 to 31 May 2017 were each matched to two to three controls who were alive at the date of death (108 controls matched on age and time since diagnosis). Covariates included demographics, substance use, housing status, medical conditions, and care indicators from the study population. We used matched-pair conditional logistic regression to examine factors associated with mortality. RESULTS: Of the 156 PWH in the study, 14% were African-American, 14% Latino, and 8% female sex. In adjusted analysis, factors associated with higher odds of death included: homelessness at HIV diagnosis [adjusted odds ratio (AOR) = 27.4; 95% confidence interval (CI) = 3.0-552.1], prior-year IDU (AOR = 10.2; 95% CI = 1.7-128.5), prior-year tobacco use (AOR = 7.2; 95% CI = 1.7-46.9), being off antiretroviral therapy at any point in the prior year (AOR = 6.8; 95% CI = 1.1-71.4), and being unpartnered vs. married/partnered (AOR = 4.7; 95% CI = 1.3-22.0). CONCLUSION: People homeless at HIV diagnosis had 27-fold higher odds of death compared with those with housing; substance use and retention on antiretroviral therapy in the prior year are other important intervenable factors. New strategies to address these barriers, and continued investment in supportive housing and substance use treatment, are needed.
OBJECTIVE:San Francisco, California, has experienced a 44% reduction in new HIV diagnoses since 2013 supported by its 'Getting to Zero' initiative; however, the age-adjusted mortality rate in people with HIV (PWH) has not decreased. We sought to identify factors associated with death among PWH in San Francisco. DESIGN: Population-based incidence-density case-control study. METHODS: Among PWH in the San Francisco HIV surveillance registry, a random sample of 48 decedents from 1 July 2016 to 31 May 2017 were each matched to two to three controls who were alive at the date of death (108 controls matched on age and time since diagnosis). Covariates included demographics, substance use, housing status, medical conditions, and care indicators from the study population. We used matched-pair conditional logistic regression to examine factors associated with mortality. RESULTS: Of the 156 PWH in the study, 14% were African-American, 14% Latino, and 8% female sex. In adjusted analysis, factors associated with higher odds of death included: homelessness at HIV diagnosis [adjusted odds ratio (AOR) = 27.4; 95% confidence interval (CI) = 3.0-552.1], prior-year IDU (AOR = 10.2; 95% CI = 1.7-128.5), prior-year tobacco use (AOR = 7.2; 95% CI = 1.7-46.9), being off antiretroviral therapy at any point in the prior year (AOR = 6.8; 95% CI = 1.1-71.4), and being unpartnered vs. married/partnered (AOR = 4.7; 95% CI = 1.3-22.0). CONCLUSION:People homeless at HIV diagnosis had 27-fold higher odds of death compared with those with housing; substance use and retention on antiretroviral therapy in the prior year are other important intervenable factors. New strategies to address these barriers, and continued investment in supportive housing and substance use treatment, are needed.
Authors: Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman Journal: Clin Infect Dis Date: 2011-03-15 Impact factor: 9.079
Authors: Frederick L Altice; R Douglas Bruce; Gregory M Lucas; Paula J Lum; P Todd Korthuis; Timothy P Flanigan; Chinazo O Cunningham; Lynn E Sullivan; Pamela Vergara-Rodriguez; David A Fiellin; Adan Cajina; Michael Botsko; Vijay Nandi; Marc N Gourevitch; Ruth Finkelstein Journal: J Acquir Immune Defic Syndr Date: 2011-03-01 Impact factor: 3.731
Authors: Jacob A Udell; Philippe Gabriel Steg; Benjamin M Scirica; Sidney C Smith; E Magnus Ohman; Kim A Eagle; Shinya Goto; Jang Ik Cho; Deepak L Bhatt Journal: Arch Intern Med Date: 2012-07-23
Authors: Spencer Lieb; Robert G Brooks; Richard S Hopkins; Dan Thompson; Landis K Crockett; Thomas Liberti; Asim A Jani; Jeffrey P Nadler; Vikas M Virkud; Karen C West; Gayle McLaughlin Journal: J Acquir Immune Defic Syndr Date: 2002-07-01 Impact factor: 3.731
Authors: Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger Journal: Int J Epidemiol Date: 2009-10-09 Impact factor: 7.196
Authors: Sandra K Schwarcz; Ling C Hsu; Eric Vittinghoff; Annie Vu; Joshua D Bamberger; Mitchell H Katz Journal: BMC Public Health Date: 2009-07-07 Impact factor: 3.295
Authors: Charles Muiruri; Chris T Longenecker; Eric G Meissner; Nwora Lance Okeke; April C Pettit; Kevin Thomas; Eric Velazquez; Gerald S Bloomfield Journal: Prog Cardiovasc Dis Date: 2020-02-11 Impact factor: 8.194
Authors: Elizabeth Gregg; Carrie Linn; Emma Nace; Lillian Gelberg; Brianna Cowan; Jennifer A Fulcher Journal: J Prim Care Community Health Date: 2020 Jan-Dec
Authors: Matthew A Spinelli; Nancy A Hessol; Sandra K Schwarcz; Susan Scheer; Monica Gandhi; Ling Chin Hsu Journal: Open Forum Infect Dis Date: 2021-03-20 Impact factor: 3.835
Authors: Elizabeth Imbert; Matthew D Hickey; Angelo Clemenzi-Allen; Elizabeth Lynch; John Friend; Jackelyn Kelley; Madellena Conte; Doyel Das; Jan Bing Del Rosario; Erin Collins; Jon Oskarsson; Mary Lawrence Hicks; Elise D Riley; Diane V Havlir; Monica Gandhi Journal: AIDS Date: 2021-07-01 Impact factor: 4.632
Authors: Matthew A Spinelli; Nicole Laborde; Patrick Kinley; Ryan Whitacre; Hyman M Scott; Nicole Walker; Albert Y Liu; Monica Gandhi; Susan P Buchbinder Journal: J Int AIDS Soc Date: 2020-04 Impact factor: 5.396